Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

Haghdoost-Yazdi, Hashem; Faraji, Ayda; Fraidouni, Negin; Movahedi, Mohadeseh; Hadibeygi, Elham; Vaezi, Fatemeh

Haghdoost-Yazdi, Hashem; Faraji, Ayda; Fraidouni, Negin; Movahedi, Mohadeseh; Hadibeygi, Elham; Vaezi, Fatemeh.

Affiliation

Haghdoost-Yazdi H; Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin 3419759811, Iran. hhaghdoost@yahoo.com

Behav Brain Res ; 223(1): 70-4, 2011 Sep 30.

Article in En | MEDLINE | ID: mdl-21540059

Subject(s)

4-Aminopyridine/therapeutic use; Behavior, Animal/drug effects; Oxidopamine; Parkinson Disease, Secondary/chemically induced; Parkinson Disease, Secondary/drug therapy; Potassium Channel Blockers/therapeutic use; Tetraethylammonium/therapeutic use; 4-Aminopyridine/pharmacology; Animals; Apomorphine/antagonists & inhibitors; Apomorphine/pharmacology; Disease Models, Animal; Drug Interactions; Male; Medial Forebrain Bundle/drug effects; Microinjections; Potassium Channel Blockers/pharmacology; Rats; Rats, Wistar; Tetraethylammonium/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease, Secondary / Behavior, Animal / 4-Aminopyridine / Oxidopamine / Tetraethylammonium / Potassium Channel Blockers Type of study: Prognostic_studies Aspects: Patient_preference Limits: Animals Language: En Journal: Behav Brain Res Year: 2011 Document type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google